Activation of Src signaling mediates acquired resistance to ALK inhibition in lung cancer
Ryohei Yoshida(Asahikawa Medical University), Yoshinobu Ohsaki(Asahikawa Medical College Hospital)
Cited by 34
Related Papers
MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer
|Cancer Cell|2022|101
Tumor-Derived cGAMP Regulates Activation of the Vasculature
|Frontiers in Immunology|2020|61
MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer
|Cancer Research|2022|38
The feasibility of circulating tumor DNA analysis as a marker of recurrence in triple-negative breast cancer
|Oncology Letters|2021|7
SETD2 and miR-21 as therapeutic targets for NUT midline carcinoma
|Research Square|2021|0